Lazard Asset Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-3,114
Closed -$117K – 2279
2024
Q3
$117K Buy
+3,114
New +$120K ﹤0.01% 1747
2023
Q1
– Sell
-3,107
Closed -$99K – 2293
2022
Q4
$99K Buy
3,107
+1,505
+94% +$51.2K ﹤0.01% 1537
2022
Q3
$57K Sell
1,602
-1,623
-50% -$67.4K ﹤0.01% 1737
2022
Q2
$132K Buy
3,225
+1,325
+70% +$64.4K ﹤0.01% 1400
2022
Q1
$110K Buy
+1,900
New +$104K ﹤0.01% 1369

Other funds holding ATEX

Lazard Asset Management's ATEX Position: Q4 2024 in Review

Lazard Asset Management sold out of Anterix (ATEX) in Q4 2024, closing a stake of 3,114 shares — an estimated $117K sold.

Lazard Asset Management first reported a position in ATEX in Q1 2022 and held it in 5 quarters. The position peaked at $132K in Q2 2022. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.

  • Lazard Asset Management reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
  • Lazard Asset Management sold 3,114 Anterix shares in Q4 2024, an estimated $117K.
  • Lazard Asset Management first reported a position in Anterix in Q1 2022 and held it in 5 quarters.
  • Lazard Asset Management's Anterix position peaked at $132K in Q2 2022.
  • 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.